Tregs at the site of the infection or at the TME secrete negative regulatory cytokines, IL-10 and TGF-β, to promote immune suppression (122), thereby limiting anti-pathogen or anti-tumor activity of effector T cells. The gene discussed is IL10; the disease is neoplasm.